Table 6.
HCQ inhibits complement activation in vivo.
Complement split products C3adesArg and C5adesArg in serum from NHIgG-treated mice, APS-mice and APS-mice treated with HCQ. N=5-6 mice/experimental group. *Different from NHIgG, p<0.05
C3a (ng/ml) | C5a (ng/ml) | |
---|---|---|
NHIgG | 43±7 | 21±5 |
APS | 156±34* | 142±31* |
APS + HCQ | 57±21 | 35±11 |
HCQ | 39±9 | 18±7 |